Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Types Of Responders Of Hapatitis B Vaccine"

00:12 EDT 28th July 2014 | BioPortfolio

Original Source: Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders

Hepatitis B is a vaccine preventable infection which can be transmitted through occupational exposure. Approximately 15% of patients will not respond to an initial series of vaccination. Of those re-vaccinated approximately fifty percent will respond. On the basis of poor response to a third series, repeat vaccination is not recommended and non-responders are considered vulnerable to infection. Cardell studied the use of double dose combination hepatitis A and B vaccine (Tw...

Matching Channels

Streptococcal streptococcus pneumoniae vaccine

Pneumococcal disease is a leading cause of serious illness in children and adults throughout the world. The disease is caused by a common bacterium, Streptococcus pneumoniae, or pneumococcus, a gram-p...


Types of stents

HPV vaccine

Types of cognitive error

Matching News

Merck's 9-valent HPV vaccine V503 under FDA review

Merck already markets Gardasil, a quadrivalent vaccine directed against HPV types 6, 11, 16 and 18.

What Parents Should Know about Cancer and the HPV Vaccine

We can vaccinate our children against polio, against measles, against the flu. And more recently a vaccine has become available that lets parents give their children a new leg up against disease—a v...

New target discovered for dengue virus vaccine

By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potenti...

Mining the genomes of exceptional responders

The National Cancer Institute of the United States recently announced a major new initiative in understanding the genomes or, more broadly, the molecular phenotypes of exceptional responders. What can...

Fewer HPV vaccine doses still protect against genital warts in girls

Although the main purpose of the human papillomavirus vaccine is to protect girls from cervical cancer, genital warts caused by certain types of the virus is also prevented by the vaccine. Now, resear...

Researchers team up to find new target for dengue virus vaccine

Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target for...

FDA to review Merck's HPV vaccine

FDA accepted for review a BLA from Merck & Co. Inc. (NYSE:MRK) for V503 to prevent HPV infection. Merck declined to disclose when it expects a decision on the nonavalent HPV vaccine. V503 would vaccin...

Researchers discover new target for human antibodies that holds key to vaccine for dengue

​Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target f...

Matching PubMed Articles

HPV Vaccine Works against Nine Viral Types.

In a phase III study, Merck's V503 human papillomavirus (HPV) vaccine prevented 97% of high-grade, precancerous vaginal, vulvar, and cervical disease caused by HPV types 31, 33, 45, 52, and 58. The ne...

Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003-2006.

A vaccine is available to prevent human papillomavirus (HPV) 6, 11, 16 and 18; in the prevaccine era, seropositivity to vaccine types is a measure of natural exposure.

Development of Neutralizing Monoclonal Antibodies for Oncogenic HPV Types 31, 33, 45, 52, and 58.

Human Papillomavirus (HPV) is the etiological agent for all cervical cancers, a significant number of other anogenital cancers, and a growing number of head-and-neck cancers. Two licensed vaccines off...

Differential Blood and Mucosal Immune Responses against an HIV-1 Vaccine Administered via Inguinal or Deltoid Injection.

Mucosal immunity is central to sexual transmission and overall pathogenesis of HIV-1 infection, but the ability of vaccines to induce immune responses in mucosal tissue compartments is poorly defined....

Cross-neutralizing antibodies elicited by the Cervarix(®) human papillomavirus vaccine display a range of Alpha-9 inter-type specificities.

The highly efficacious human papillomavirus (HPV) vaccines contain virus-like particles (VLP) representing genotypes HPV16 and HPV18, which together account for approximately 70% of cervical cancer ca...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement